Literature DB >> 29750230

The role of novel atherosclerosis markers in peripheral artery disease: is there a gender difference?

Hora Iu Comşa1, Dumitru Zdrenghea1, Sorin Claudiu Man2, Dana Pop1.   

Abstract

Peripheral arterial disease (PAD) represents a major public health problem due to its high and increasing prevalence, worldwide distribution, and significant morbidity and mortality rate. Female gender is a risk factor for PAD globally and especially in low-income countries. In this review, we summarise the present knowledge regarding the role of novel atherosclerosis markers in the development of PAD in women. We discuss inflammatory markers, cytokines, cellular adhesion molecules, markers of oxidative stress and other circulating markers, and their role in the prediction of presence, severity and complications of PAD, with particular emphasis on gender. Although many PAD biomarkers are indicative of PAD in both males and females, some are strongly correlated with the disease in females. These gender differences could be useful for the early identification and management of PAD in women.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29750230      PMCID: PMC8962700          DOI: 10.5830/CVJA-2018-023

Source DB:  PubMed          Journal:  Cardiovasc J Afr        ISSN: 1015-9657            Impact factor:   1.167


  108 in total

1.  Lipoprotein (a), LPA Ile4399Met, and fibrin clot properties.

Authors:  Charles M Rowland; Clive R Pullinger; May M Luke; Dov Shiffman; Lauri Green; Irina Movsesyan; James J Devlin; Mary J Malloy; John P Kane; Anetta Undas
Journal:  Thromb Res       Date:  2014-01-26       Impact factor: 3.944

2.  Patterns of inflammation associated with peripheral arterial disease: the InCHIANTI study.

Authors:  Mary McGrae McDermott; Jack M Guralnik; Annamaria Corsi; Monique Albay; Claudio Macchi; Stefania Bandinelli; Luigi Ferrucci
Journal:  Am Heart J       Date:  2005-08       Impact factor: 4.749

3.  Imbalance between nitric oxide generation and oxidative stress in patients with peripheral arterial disease: effect of an antioxidant treatment.

Authors:  Lorenzo Loffredo; Pasquale Pignatelli; Roberto Cangemi; Paola Andreozzi; Maria Antonietta Panico; Valerio Meloni; Francesco Violi
Journal:  J Vasc Surg       Date:  2006-09       Impact factor: 4.268

4.  Elevated serum C-reactive protein levels and early arterial changes in healthy children.

Authors:  Mikko J Järvisalo; Aimo Harmoinen; Maarit Hakanen; Ulla Paakkunainen; Jorma Viikari; Jaakko Hartiala; Terho Lehtimäki; Olli Simell; Olli T Raitakari
Journal:  Arterioscler Thromb Vasc Biol       Date:  2002-08-01       Impact factor: 8.311

5.  Higher serum levels of soluble intracellular cell adhesion molecule-1 and soluble vascular cell adhesion molecule predict peripheral artery disease in haemodialysis patients.

Authors:  Chi-Hung Cheng; Yi-Shyan Chen; Kuo-Hsiung Shu; Horng-Rong Chang; Ming-Chih Chou
Journal:  Nephrology (Carlton)       Date:  2012-11       Impact factor: 2.506

6.  Adiponectin, resistin and IL-6 plasma levels in subjects with diabetic foot and possible correlations with clinical variables and cardiovascular co-morbidity.

Authors:  Antonino Tuttolomondo; Sergio La Placa; Domenico Di Raimondo; Chiara Bellia; Antonietta Caruso; Bruna Lo Sasso; Giovanni Guercio; Giuseppe Diana; Marcello Ciaccio; Giuseppe Licata; Antonio Pinto
Journal:  Cardiovasc Diabetol       Date:  2010-09-13       Impact factor: 9.951

7.  Beta2-microglobulin for risk stratification of total mortality in the elderly population: comparison with cystatin C and C-reactive protein.

Authors:  Shoji Shinkai; Paulo H M Chaves; Yoshinori Fujiwara; Shuichiro Watanabe; Hiroshi Shibata; Hideyo Yoshida; Takao Suzuki
Journal:  Arch Intern Med       Date:  2008-01-28

8.  A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes.

Authors:  C J Boushey; S A Beresford; G S Omenn; A G Motulsky
Journal:  JAMA       Date:  1995-10-04       Impact factor: 56.272

9.  Plasma free H2S levels are elevated in patients with cardiovascular disease.

Authors:  Elvis A Peter; Xinggui Shen; Shivang H Shah; Sibile Pardue; John D Glawe; Wayne W Zhang; Pratap Reddy; Nuri I Akkus; Jai Varma; Christopher G Kevil
Journal:  J Am Heart Assoc       Date:  2013-10-23       Impact factor: 5.501

10.  Relation Between Circulating Inflammatory Chemokines and Vascular Characteristics in Healthy, Young Children.

Authors:  Anouk L M Eikendal; Annemieke M V Evelein; Cuno S P M Uiterwaal; Cornelis K van der Ent; Frank L J Visseren; Michiel L Bots; Imo E Hoefer; Hester M den Ruijter; Geertje W Dalmeijer
Journal:  J Am Heart Assoc       Date:  2015-12-16       Impact factor: 5.501

View more
  3 in total

1.  CircNMD3 relieves endothelial cell injury induced by oxidatively modified low-density lipoprotein through regulating miR-498/ BMP and activin membrane-bound inhibitor (BAMBI) axis.

Authors:  Jian Xiu; Zheng Yang; Yanbo Sui; Lin Zhang; Yixing Zhou
Journal:  Bioengineered       Date:  2022-05       Impact factor: 6.832

2.  Uterus transplant graft's arterial atherosclerotic remodeling veracity.

Authors:  Robert Novotny; Jaroslav Chlupac; Jakub Kristek; Jan Pit'ha; Roman Chmel; Eva Sticova; Libor Janousek; Jiri Fronek
Journal:  Medicine (Baltimore)       Date:  2020-01       Impact factor: 1.817

3.  Micro-RNA-338-3p Promotes the Development of Atherosclerosis by Targeting Desmin and Promoting Proliferation.

Authors:  Shiran Yan; Jing Chen; Teng Zhang; Jian Zhou; Ge Wang; Yanfen Li
Journal:  Mol Biotechnol       Date:  2021-06-07       Impact factor: 2.695

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.